This summer, IVCC partnered with Malaria No More UK and the National Malaria Elimination Programme (NMEP) Ghana to host a visit by three UK Members of Parliament. The delegation, Wendy…
IVCC representatives met with the All-Party Parliamentary Group (APPG) on Malaria and Neglected Tropical Diseases in London this month. Our CEO, Communications Director, and Technical Director joined the meeting with…
IVCC participated in the 2024 Global Health Security Conference in Sydney, from the 18th to the 21st of June. The event brought together leaders, researchers, policy makers and representatives from private industry,…
During last week’s Labour Party Conference, IVCC’s CEO Justin McBeath attended a breakfast roundtable hosted by Malaria No More UK. The roundtable offered the opportunity to present key voices…
From September 19th to 23rd, IVCC attended the International Congress for Tropical Medicine and Malaria(ICTMM) 2024 in Kuching, Malaysia. This congress, hosted by the International Federation for Tropical Medicine, highlighted global efforts…
IVCC will participate at the 2024 Annual Meeting of the American Society of Tropical Medicine (ASTMH) in New Orelans, USA, taking place between 13th and 17th November. Visit our booth…
IVCC participated in the 20th Annual Meeting of the Vector Control Working Group (VCWG), hosted by the RBM Partnership to End Malaria, taking place 3–5 March in Cotonou, Benin. This…
VECTRON™ T500, developed by Mitsui Chemicals Crop & Life Solutions with TENEBENAL™, achieved WHO pre-qualification, marking the world’s first meta-diamide active ingredient (IRAC Group 30) for vector control.
IVCC supported Sumitomo Chemical in developing SumiShield® 50WG IRS, a new tool for managing resistance. This product, prequalified by WHO, offers a breakthrough in indoor residual spraying.
IVCC supported the development of Bayer’s Fludora™ Fusion IRS, tested against resistant mosquito strains and various surfaces, leading to its WHO Pre-Qualification.